Pricing Log in Create free account
Saturday 17 October 2026 Export RMD’s income statement to Excel — free account

ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

238.97 3.26 −1.35%
Market cap
$34.1B
P/E
22.8×
Fwd P/E
16.6×
Dividend yield
1.03%
F-score
6/9
Altman Z
10.00
Beneish M
−2.59
Dividend safety
96/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

ResMed Inc. (RMD) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, ResMed Inc. (RMD) trades at a P/B ratio of 5.3×. Over the past ten years it has ranged from 4.1× (June 2026) to 15.0× (September 2021); the current reading is higher than 17% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2026 4.3× (32.11%)
FY2025 6.3× 12.25%
FY2024 5.7× (27.23%)
FY2023 7.8× (14.77%)
FY2022 9.1× (26.61%)
FY2021 12.4× 11.85%
FY2020 11.1× 29.85%
FY2019 8.5× 18.78%
FY2018 7.2× 28.14%
FY2017 5.6× 7.33%

Quarterly newest first

Period P/B ratio Change
Jun 2026 4.3× (14.31%)
Mar 2026 5.0× (9.57%)
Dec 2025 5.6× (14.98%)
Sep 2025 6.5× 3.06%
42 more quarters

Against its own ten years

Low 4.1× High 15.0×
Ten-year median 6.8×
Current reading's percentile 15

P/B ratio against peers

Company P/B ratio
COO The Cooper Companies, Inc. compare 1.3×
ALC Alcon compare 1.5×
MDLN Medline Inc. compare 1.6×
BAX Baxter International Inc. compare 2.1×
BDX Becton, Dickinson and Company compare 2.2×
SOLV Solventum Corporation compare 3.1×
RGEN Repligen Corporation compare 4.7×
RMD ResMed Inc. 5.3×
WST West Pharmaceutical Services, Inc. compare 9.1×
Medical Instruments & Supplies industry median 2.5×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on RMD